Cordium Pharmaceuticals Pvt Ltd offers pharmaceutical sourcing and international supply solutions for Goserelin 3.6 mg and 10.8 mg Injection/Implant for eligible healthcare buyers, distributors, pharmacies and authorized importers across the USA, UK, UAE and South Africa.
Goserelin is a GnRH agonist used in selected hormone-sensitive conditions, including prostate cancer, breast cancer and endometriosis. The 3.6 mg formulation is generally administered every 28 days, while the 10.8 mg formulation is designed for longer-acting treatment, commonly every 12 weeks for approved prostate cancer indications.
Goserelin Injection Supply from India
Cordium Pharmaceuticals Pvt Ltd supports international pharmaceutical supply from India with a focus on:
Goserelin 3.6 mg and 10.8 mg requirements
Hospital and pharmacy supply
Pharmaceutical distributor orders
Export documentation support
International shipping coordination
Bulk and repeat procurement requirements
Supply to authorized importers and healthcare organizations
Product availability, registration, prescription requirements and import regulations can vary by destination country.
Goserelin 3.6 mg/10.8 mg Uses
Goserelin may be prescribed for selected:
Prostate cancer treatments
Hormone-sensitive breast cancer
Endometriosis
Endometrial thinning
Certain gynecological conditions
The licensed indications differ between countries and individual products.
Goserelin Dosage Information
Goserelin 3.6 mg: commonly administered as a subcutaneous depot every 28 days.
Goserelin 10.8 mg: commonly administered as a subcutaneous depot every 12 weeks for approved prostate cancer indications.
Goserelin should be administered by an appropriately trained healthcare professional. Dosage and treatment duration must be determined by the prescribing physician.
Supply to USA, UK, UAE & South Africa
USA
Cordium Pharmaceuticals Pvt Ltd can support inquiries from authorized U.S. healthcare and pharmaceutical buyers, subject to applicable import and regulatory requirements.
UK
Goserelin 3.6 mg and 10.8 mg products are recognized in UK medicine information. UK buyers should verify applicable licensing, prescription and import requirements.
UAE
Cordium Pharma can assist authorized UAE buyers with pharmaceutical sourcing and export coordination, subject to UAE regulatory and import requirements.
South Africa
Healthcare organizations and authorized importers in South Africa can contact Cordium Pharma for Goserelin sourcing requirements, subject to local regulations.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
India-based pharmaceutical exporter
International B2B supply support
Hospital and distributor-focused sourcing
Export documentation assistance
Professional order coordination
Support for international pharmaceutical shipments
Focus on quality-oriented pharmaceutical sourcing
Frequently Asked Questions
Can I source Goserelin 3.6 mg/10.8 mg from India?
Yes. Cordium Pharmaceuticals Pvt Ltd can assist eligible international buyers with sourcing inquiries, subject to product availability and destination-country regulations.
What is the difference between Goserelin 3.6 mg and 10.8 mg?
The primary difference is the amount of goserelin and dosing interval. The 3.6 mg depot is generally administered every 28 days, while the 10.8 mg depot provides approximately 12 weeks of treatment for approved indications.
Who can purchase Goserelin?
Goserelin is a prescription medicine. Supply should be made to appropriately authorized pharmacies, hospitals, distributors, healthcare organizations or importers in accordance with local law.
Does Cordium Pharma supply internationally?
Cordium Pharmaceuticals Pvt Ltd provides international pharmaceutical export and supply support from India for eligible markets.
Get a Goserelin Supply Quote
For Goserelin 3.6 mg/10.8 mg Injection supply from India, authorized buyers can contact Cordium Pharmaceuticals Pvt Ltd for product availability, quotation, order requirements and international export coordination.
Disclaimer: Goserelin is a prescription medicine. Product indications, availability, import requirements and regulatory status vary by country. This content is intended for pharmaceutical sourcing information and does not replace professional medical advice or official prescribing information.
Goserelin is a GnRH agonist used in selected hormone-sensitive conditions, including prostate cancer, breast cancer and endometriosis. The 3.6 mg formulation is generally administered every 28 days, while the 10.8 mg formulation is designed for longer-acting treatment, commonly every 12 weeks for approved prostate cancer indications.
Goserelin Injection Supply from India
Cordium Pharmaceuticals Pvt Ltd supports international pharmaceutical supply from India with a focus on:
Goserelin 3.6 mg and 10.8 mg requirements
Hospital and pharmacy supply
Pharmaceutical distributor orders
Export documentation support
International shipping coordination
Bulk and repeat procurement requirements
Supply to authorized importers and healthcare organizations
Product availability, registration, prescription requirements and import regulations can vary by destination country.
Goserelin 3.6 mg/10.8 mg Uses
Goserelin may be prescribed for selected:
Prostate cancer treatments
Hormone-sensitive breast cancer
Endometriosis
Endometrial thinning
Certain gynecological conditions
The licensed indications differ between countries and individual products.
Goserelin Dosage Information
Goserelin 3.6 mg: commonly administered as a subcutaneous depot every 28 days.
Goserelin 10.8 mg: commonly administered as a subcutaneous depot every 12 weeks for approved prostate cancer indications.
Goserelin should be administered by an appropriately trained healthcare professional. Dosage and treatment duration must be determined by the prescribing physician.
Supply to USA, UK, UAE & South Africa
USA
Cordium Pharmaceuticals Pvt Ltd can support inquiries from authorized U.S. healthcare and pharmaceutical buyers, subject to applicable import and regulatory requirements.
UK
Goserelin 3.6 mg and 10.8 mg products are recognized in UK medicine information. UK buyers should verify applicable licensing, prescription and import requirements.
UAE
Cordium Pharma can assist authorized UAE buyers with pharmaceutical sourcing and export coordination, subject to UAE regulatory and import requirements.
South Africa
Healthcare organizations and authorized importers in South Africa can contact Cordium Pharma for Goserelin sourcing requirements, subject to local regulations.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
India-based pharmaceutical exporter
International B2B supply support
Hospital and distributor-focused sourcing
Export documentation assistance
Professional order coordination
Support for international pharmaceutical shipments
Focus on quality-oriented pharmaceutical sourcing
Frequently Asked Questions
Can I source Goserelin 3.6 mg/10.8 mg from India?
Yes. Cordium Pharmaceuticals Pvt Ltd can assist eligible international buyers with sourcing inquiries, subject to product availability and destination-country regulations.
What is the difference between Goserelin 3.6 mg and 10.8 mg?
The primary difference is the amount of goserelin and dosing interval. The 3.6 mg depot is generally administered every 28 days, while the 10.8 mg depot provides approximately 12 weeks of treatment for approved indications.
Who can purchase Goserelin?
Goserelin is a prescription medicine. Supply should be made to appropriately authorized pharmacies, hospitals, distributors, healthcare organizations or importers in accordance with local law.
Does Cordium Pharma supply internationally?
Cordium Pharmaceuticals Pvt Ltd provides international pharmaceutical export and supply support from India for eligible markets.
Get a Goserelin Supply Quote
For Goserelin 3.6 mg/10.8 mg Injection supply from India, authorized buyers can contact Cordium Pharmaceuticals Pvt Ltd for product availability, quotation, order requirements and international export coordination.
Disclaimer: Goserelin is a prescription medicine. Product indications, availability, import requirements and regulatory status vary by country. This content is intended for pharmaceutical sourcing information and does not replace professional medical advice or official prescribing information.
Keywords
